CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

Clinical trial NCT00333190 · COMPLETED

Trial details

NCT number: NCT00333190
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hematologic Malignancy AML ALL CML Multiple Myeloma NHL Hodgkin's Lymphoma

Start date: 2005-09-01
Primary completion: 2007-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.